Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


1 Br J Cancer
1 Cancer
2 Cancer Res
2 Clin Cancer Res
1 Gynecol Oncol
1 Int J Cancer
2 J Clin Oncol
1 Nat Med
1 Obstet Gynecol
1 Oncol Rep
4 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Br J Cancer

  1. GORANOVA T, Ennis D, Piskorz AM, Macintyre G, et al
    Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.
    Br J Cancer. 2017 Mar 30. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


  2. GREENWALD ZR, Huang LN, Wissing MD, Franco EL, et al
    Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30529.
    PubMed     Text format     Abstract available

    Cancer Res

  3. JUNG M, Russell AJ, Liu B, George J, et al
    A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.
    Cancer Res. 2017;77:971-981.
    PubMed     Text format     Abstract available

  4. WALTON J, Blagih J, Ennis D, Leung E, et al
    CRISPR/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high grade serous carcinoma.
    Cancer Res. 2016 Aug 16. pii: canres.1272.2016.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  5. LIU J, Agopiantz M, Poupon J, Wu Z, et al
    Neurotensin receptor 1 antagonist SR48692 improves response to carboplatin by enhancing apoptosis and inhibiting drug efflux in ovarian cancer.
    Clin Cancer Res. 2017 Aug 8. pii: clincanres.0861.2017.
    PubMed     Text format     Abstract available

  6. CORNELISON R, Dobbin ZC, Katre AA, Jeong DH, et al
    Clin Cancer Res. 2017 Aug 4. pii: clincanres.0282.2017.
    PubMed     Text format     Abstract available

    Gynecol Oncol

  7. BOGANI G, Tagliabue E, Ditto A, Signorelli M, et al
    Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
    Gynecol Oncol. 2017 Aug 2. pii: S0090-8258(17)31179.
    PubMed     Text format     Abstract available

    Int J Cancer

  8. MORCH LS, Dehlendorff C, Baandrup L, Friis S, et al
    Use of antidepressants and risk of epithelial ovarian cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30919.
    PubMed     Text format     Abstract available

    J Clin Oncol

  9. MOORE KN, Martin LP, O'Malley DM, Matulonis UA, et al
    Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
    J Clin Oncol. 2017;35:1112-1118.
    PubMed     Text format     Abstract available

  10. GERSHENSON DM, Bodurka DC, Coleman RL, Lu KH, et al
    Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum.
    J Clin Oncol. 2017;35:1103-1111.
    PubMed     Text format     Abstract available

    Nat Med

  11. DAVIES H, Glodzik D, Morganella S, Yates LR, et al
    HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
    Nat Med. 2017;23:517-525.
    PubMed     Text format     Abstract available

    Obstet Gynecol

  12. WRIGHT JD, Chen L, Hou JY, Burke WM, et al
    Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer.
    Obstet Gynecol. 2017 Aug 4. doi: 10.1097/AOG.0000000000002164.
    PubMed     Text format     Abstract available

    Oncol Rep

  13. JIA L, Zhou J, Zhao H, Jin H, et al
    Corilagin sensitizes epithelial ovarian cancer to chemotherapy by inhibiting Snailglycolysis pathways.
    Oncol Rep. 2017 Aug 7. doi: 10.3892/or.2017.5886.
    PubMed     Text format     Abstract available

    PLoS One

  14. PAULLIN T, Powell C, Menzie C, Hill R, et al
    Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses.
    PLoS One. 2017;12:e0182930.
    PubMed     Text format     Abstract available

  15. ROZENBLUM E, Sotelo-Silveira JR, Kim GY, Zhu JY, et al
    Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor.
    PLoS One. 2017;12:e0182610.
    PubMed     Text format     Abstract available

  16. PETERS IT, van Zwet EW, Smit VT, Liefers GJ, et al
    Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.
    PLoS One. 2017;12:e0168277.
    PubMed     Text format     Abstract available

  17. ZHU J, Wen H, Ju X, Bi R, et al
    Clinical Significance of Programmed Death Ligand1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma.
    PLoS One. 2017;12:e0170879.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.